Purkinje cell (PC) antibody positivity in a patient with autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy
- 30 December 2020
- journal article
- case report
- Published by Taylor & Francis in International Journal of Neuroscience
- Vol. 132 (10) , 1043-1048
Abstract
Purpose: This case report is the first to describe the detection of antibodies against inositol 1,4,5-trisphosphate receptor 1 (ITPR1, I3PR) in a patient diagnosed with autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy. ITPR1 is known as one of the Purkinje cell antibodies present in autoimmune cerebellar ataxia (ACA). Here, we described the association between autoimmune GFAP astrocytopathy and autoimmune cerebellar disease (ACD). Materials and methods: Demographic features, clinical characteristics, cerebrospinal fluid (CSF) parameters and neuroimaging findings were collected from this patient. Specifically, antibodies against GFAP and other proteins associated with neurological disorders were measured by immunofluorescence staining in both serum and CSF samples. Results: A 52-year-old woman was diagnosed with autoimmune inflammatory meningoencephalitis. She presented with cognitive dysfunction, psychiatric/behavioral abnormalities and serious insomnia with subacute onset. Brain magnetic resonance imaging (MRI) showed bilateral hyperintensity in the semioval centers on axial images and perivascular linear enhancement oriented radially to the ventricles on sagittal images. GFAP-IgG, oligoclonal bands (OBs), N-methyl-D-aspartate receptor (NMDAR)–IgG and ITPR1-IgG coexisted in her CSF. She responded well to immunoglobulin and steroid treatments. Conclusion: Here, we describe the case of a patient with autoimmune GFAP astrocytopathy whose CSF was positive for ITPR1-IgG; however, she did not show typical ataxia manifestations or cerebellar lesions on her MRI scan. This suggests that ITPR1-IgG is not pathogenic, and the positivity of this antibody in CSF is probably associated with the presence of autoimmune inflammation.Keywords
This publication has 16 references indexed in Scilit:
- Autoimmune GFAP astrocytopathy: Prospective evaluation of 90 patients in 1 yearJournal of Neuroimmunology, 2018
- Glial fibrillary acidic protein IgG related myelitis: characterisation and comparison with aquaporin-4-IgG myelitisJournal of Neurology, Neurosurgery & Psychiatry, 2018
- Overlapping Autoimmune Syndromes in Patients With Glial Fibrillary Acidic Protein AntibodiesFrontiers in Neurology, 2018
- Autoimmune glial fibrillary acidic protein astrocytopathy in Chinese patients: a retrospective studyEuropean Journal of Neurology, 2017
- Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patientsJournal of Neurology, Neurosurgery & Psychiatry, 2017
- Treatment of Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: Follow-Up in 7 CasesNeuroimmunomodulation, 2017
- Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: Analysis of 102 patientsAnnals of Neurology, 2017
- Autoimmune Glial Fibrillary Acidic Protein AstrocytopathyJAMA Neurology, 2016
- Antibodies to the inositol 1,4,5-trisphosphate receptor type 1 (ITPR1) in cerebellar ataxiaJournal of Neuroinflammation, 2014
- Targeted deletion in astrocyte intermediate filament (Gfap) alters neuronal physiology.Proceedings of the National Academy of Sciences, 1996